Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Strattera (atomoxetine) - Important Safety Information from Eli Lilly as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
13/12/2011
Problem Or Issue:
Important Safety Information communication from Eli Lilly regarding new clinically important information about the known risks of increased blood pressure and increased heart rate with the use of Strattera (atomoxetine) for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
Important Safety Information - Strattera
« Back
Date Printed: 08/05/2024